查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
胎兒監測、診斷和預測測試
市場調查報告書
商品編碼
1249903

胎兒監測、診斷和預測測試

Fetal Monitoring, Diagnostics and Predictive Tests
出版日期: | 出版商: BCC Research | 英文 235 Pages | 訂單完成後即時交付

價格

全球胎兒監護、診斷和預測性檢測市場預計將從 2022 年的 104 億美元增長到 2027 年的 136 億美元，預測期內復合年增長率為 5.6%。

到 2027 年，產前診斷行業預計將從 2022 年的 83 億美元增長到 109 億美元，複合年增長率為 5.7%。 到 2027 年，胎兒監護行業預計將從 2022 年的 18 億美元增長到 23 億美元，複合年增長率為 5.1%。

本報告調查了全球胎兒監護/診斷/預測測試市場，提供了市場和技術背景、法律和監管環境、市場規模轉變/預測、應用/技術的詳細分析、競爭格局，其中包括主要公司的概況.

內容

第一章介紹

第 2 章要點摘要

第三章市場與技術背景

  • 高危妊娠
  • 胎兒生長受限
  • 早產
  • 羊水過少
  • 胎盤血流異常
  • 羊水渾濁
  • 漂白劑介紹
  • 胎兒監護供應商和產品

第 4 章市場中的新興和未來技術

  • 胎兒監護技術的進步
    • 分娩技術的變化
    • 胎兒監護的未來
    • 新的胎兒心臟監測技術

第 5 章監管結構

  • 監管框架

第 6 章市場細分：按應用

  • 市場分析
  • 市場概覽
  • 胎兒監護
    • 電子胎監
    • 胎兒多普勒
    • 其他胎兒監護儀
  • 產前診斷
    • 胎兒超聲
    • 胎兒核磁共振
    • 羊膜穿刺術和絨毛膜絨毛取樣 (CVS)
    • 非侵入性 cfDNA 檢測
    • 植入前基因診斷和篩查 (PGD/PGS)
    • 其他產前診斷（母體血清篩查）
  • 新生兒監護產品
    • 產前診斷和胎兒治療要點
    • 產前篩查測試
    • 妊娠和產前篩查測試
    • 妊娠中期母體氨基己糖甘□篩查試驗
    • 產前診斷中的放射學研究
    • 胎兒診斷中的磁共振成像
    • 胎兒護理
    • 近期趨勢：產前診斷測試
    • 懷孕預測測試
    • 染色體異常對胎兒的影響
    • 可預測的攜帶者遺傳病總數
    • 可能成為遺傳疾病的攜帶者
    • 先天缺陷的原因
    • 用於攜帶者篩查的商用基因檢測
    • 植入前基因檢測
    • 植入前基因診斷 (PGD/PGS) 技術
    • PGD 的未來

第 7 章 COVID-19 的市場影響

第八章競爭格局

  • 概覽
  • 全球公司排名
  • 進入胎兒監護行業

第九章公司簡介

  • ABBOTT LABORATORIES
  • ABCAM PLC
  • AMBISEA TECHNOLOGY CORP., LTD.
  • ANSH LABS LLC
  • ATOM MEDICAL CORP.
  • AVIVA SYSTEMS BIOLOGY LLC
  • BECKMAN COULTER INC.
  • BERRY GENOMICS
  • BIONET AMERICA INC.
  • BISTOS Co., LTD.
  • CONTEC MEDICAL SYSTEMS CO. LTD.
  • COOPERSURGICAL INC.
  • CREATIVE DIAGNOSTICS
  • DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
  • DEMEDITEC DIAGNOSTICS GMBH
  • DRAGERWERK AG & CO.
  • DRE INC.
  • DRG INTERNATIONAL INC.
  • EAGLE BIOSCIENCES INC.
  • EDAN INSTRUMENTS INC.
  • ESAOTE SPA
  • FUKUDA DENSHI CO. LTD.
  • GE HEALTHCARE LTD.
  • GENERAL MEDITECH INC.
  • HITACHI MEDICAL SYSTEMS AMERICA INC.
  • HOLOGIC INC.
  • HUNTLEIGH HEALTHCARE LLC
  • ILLUMINA INC.
  • INFINIUM MEDICAL INC.
  • INSTITUTE OF ISOTOPES CO. LTD.
  • LEINCO TECHNOLOGIES INC.
  • LIFEWAVE BIOMEDICAL INC.
  • LUTECH INDUSTRIES INC.
  • M&B ELECTRONIC INSTRUMENTS CO. LTD.
  • MEDGYN PRODUCTS INC.
  • MEDIANA CO. LTD.
  • MEDICAL ECONET GMBH
  • MEDICHECKS LTD.
  • MINDCHILD MEDICAL INC.
  • MINDRAY MEDICAL INTERNATIONAL LTD.
  • MONOBIND INC.
  • MYRIAD GENETICS INC.
  • NATERA INC.
  • NATUS MEDICAL INC.
  • NEMO HEALTHCARE BV
  • NEOVENTA MEDICAL AB
  • NIHON KOHDEN CORP.
  • NONIN MEDICAL INC.
  • OB TOOLS LTD.
  • PENLON LTD.
  • PERKINELMER LIFE AND ANALYTICAL SCIENCES INC.
  • PHOENIX PHARMACEUTICALS INC.
  • PREMAITHA HEALTH LTD.
  • QUEST DIAGNOSTICS INC.
  • RAVGEN
  • RAYBIOTECH INC.
  • RESPIRONICS INC.（PHILIPS）
  • SEQUENOM INC.
  • SHENZHEN AEON TECHNOLOGY CO. LTD.
  • SHENZHEN COMEN MEDICAL INSTRUMENTS CO. LTD.
  • SHENZHEN JUMPER MEDICAL EQUIPMENT CO. LTD.
  • SIEMENS HEALTHCARE
  • SINOHERO BIOMEDICAL ELECTRONICS CO. LTD.
  • SMITHS MEDICAL INC.
  • SPACELABS HEALTHCARE INC.
  • TOSHIBA AMERICA MEDICAL SYSTEMS INC.
  • USCN LIFE SCIENCES INC.
  • ULTRASOUND TECHNOLOGIES LTD.
  • UNITED BIORESEARCH INC.
  • UTAH MEDICAL PRODUCTS INC.
  • VCOMIN TECHNOLOGY LTD.
  • WELCH ALLYN INC.
Product Code: HLC089C

Highlights:

The global market for fetal monitoring, diagnostics and predictive tests is estimated to increase from $10.4 billion in 2022 to reach $13.6 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.

The global market for prenatal diagnostics is estimated to increase from $8.3 billion in 2022 to reach $10.9 billion by 2027, at a CAGR of 5.7% from 2022 through 2027.

The global market for fetal monitoring is estimated to increase from $1.8 billion in 2022 to reach $2.3 billion by 2027, at a CAGR of 5.1% from 2022 through 2027.

Report Scope:

This report aims to provide a comprehensive study of the global market for fetal monitoring, diagnostics, and predictive tests, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding fetal monitoring, diagnostics, and predictive tests.

An in-depth analysis of the global fetal monitoring, diagnostics and predictive tests market includes historical data and market projections on sales by application, product type, and end user. It describes the different types of fetal monitoring, diagnostics and predictive tests and their current and historical market revenues. This report also categorizes the global fetal monitoring, diagnostics and predictive tests market based on the region (North America, Europe, and Rest of the World).

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market shares.

Report Includes:

  • 17 data tables and 54 additional tables
  • Detailed overview and an up-to-date analysis of the global market for fetal monitoring, prenatal diagnostics, and predictive tests
  • Analyses of the global market trends, with historic market revenue for 2019-2021, 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the current and future market potential for fetal monitoring products, diagnostic and predictive tests, along with a detailed analysis of the competitive environment, industry trends, opportunities and penetration of emerging technologies within the industry
  • Estimation of the actual market size and revenue forecast for fetal monitoring and related markets in USD million values, and its corresponding market share analysis based on the product type, sample type, test type, end user, and region
  • A comparative study of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers
  • Updated information on the key mergers and acquisition deals, agreements, collaborations and other impactful strategies adopted by key players in the global market for fetal monitoring products, diagnostic and predictive tests
  • Identification of the major stakeholders and analysis of the company competitive landscape based on their recent market developments, financial performance, and segmental revenues
  • Descriptive company profiles of the leading global players, including Abbott Laboratories, Abcam plc, Ansh Labs LLC, Beckman Coulter Inc., Contect Medical Systems Co. Ltd., and Dragerwerk AG & Co. KGaA

Table of Contents

Chapter 1 Introduction

  • 1.1 Study Goals and Objectives
  • 1.2 What's New in This Update?
  • 1.3 Scope of Report
  • 1.4 Methodology and Information Sources
  • 1.5 Geographic Breakdown
  • 1.6 Analyst's Credentials
  • 1.7 BCC Custom Research
  • 1.8 Related BCC Research Reports

Chapter 2 Summary and Highlights

  • 2.1 Overview

Chapter 3 Market and Technology Background

  • 3.1 High-Risk Pregnancies
    • 3.1.1 Advanced Maternal Age (AMA)
    • 3.1.2 Medical Conditions Existing Before Pregnancy
    • 3.1.3 Medical Conditions Occurring During Pregnancy
    • 3.1.4 Pregnancy-Related Issues
  • 3.2 Fetal Growth Restrictions
  • 3.3 Preterm Births
    • 3.3.1 Global Epidemiology of Preterm Births
    • 3.3.2 Classification of Preterm Birth
    • 3.3.3 Preterm Birth Complications
    • 3.3.4 Causes of Preterm Birth
    • 3.3.5 Global Rates of Preterm Births
  • 3.4 Oligohydramnios
  • 3.5 Abnormal Placental Blood Flow
  • 3.6 Meconium-Stained Liquor
    • 3.6.1 Management of MSAF
  • 3.7 Breech Presentation
    • 3.7.1 Fetal Heart Rate (FHR)
    • 3.7.2 Fetal Movement
    • 3.7.3 Maternal Contraction
  • 3.8 Vendors and Products for Fetal Monitoring
    • 3.8.1 Fetoscope
    • 3.8.2 Fetal Heart Doppler
    • 3.8.3 Fetal Monitors
    • 3.8.4 Fetal Scalp Electrodes
    • 3.8.5 Telemetry
    • 3.8.6 Fetal Pulse Oximeter
    • 3.8.7 Fetal Ultrasound
    • 3.8.8 Neonatal Monitoring

Chapter 4 Emerging/Upcoming Technologies in the Market

  • 4.1 Technological Advancements in Fetal Monitoring
    • 4.1.1 Changes in Birth Technology
    • 4.1.2 Future of Fetal Monitoring
    • 4.1.3 New Fetal Heart Monitoring Technologies

Chapter 5 Regulatory Structure

  • 5.1 Regulatory Framework
    • 5.1.1 United States
    • 5.1.2 European Union (EU)
    • 5.1.3 Japan

Chapter 6 Market Breakdown by Application

  • 6.1 Market Analysis
  • 6.2 Market Overview
  • 6.3 Fetal Monitoring
    • 6.3.1 Electronic Fetal Monitors
    • 6.3.2 Fetal Dopplers
    • 6.3.3 Other Types of Fetal Monitors
  • 6.4 Prenatal Diagnostics
    • 6.4.1 Fetal Ultrasound
    • 6.4.2 Fetal MRI
    • 6.4.3 Amniocentesis and Chorionic Villus Sampling (CVS)
    • 6.4.4 Noninvasive cfDNA Tests
    • 6.4.5 Preimplantation Genetic Diagnosis and Screening (PGD/PGS)
    • 6.4.6 Other Types of Prenatal Diagnostics (Maternal Serum Screening)
  • 6.5 Neonatal Monitoring Products
    • 6.5.1 Essentials of Prenatal Diagnosis and Fetal Therapy
    • 6.5.2 Prenatal Screening Tests
    • 6.5.3 Pregnancy and Prenatal Screening Tests
    • 6.5.4 Second Trimester Maternal Hexosaminidase Screening Test
    • 6.5.5 Radiological Studies in Prenatal Diagnosis
    • 6.5.6 Magnetic Resonance Imaging in Fetal Diagnosis
    • 6.5.7 Fetal Management
    • 6.5.8 Recent Trends Prenatal Diagnostic Tests
    • 6.5.9 Predictive Tests Related to Pregnancy
    • 6.5.10 Effects of Chromosomal Defects on Fetuses
    • 6.5.11 Total Number of Predictable Carrier Genetic Diseases
    • 6.5.12 Chance of Being a Carrier of Genetic Disease
    • 6.5.13 Causes of Birth Defects
    • 6.5.14 Commercially Available Genetic Tests for Carrier Screening
    • 6.5.15 Preimplantation Genetic Testing
    • 6.5.16 Preimplantation Genetic Diagnosis (PGD/PGS) Technologies
    • 6.5.17 Future of PGD

Chapter 7 Impact of COVID-19 on the Market

  • 7.1 Overview
    • 7.1.1 Impact of COVID-19 on Fetal Monitoring, Diagnostics and Predictive Tests
    • 7.1.2 Trade Restrictions and Supply Disruptions

Chapter 8 Competitive Landscape

  • 8.1 Overview
  • 8.2 Global Company Ranking
    • 8.2.1 Other Key Players
  • 8.3 Fetal Monitoring Industry Participants
    • 8.3.1 Need for Innovations
    • 8.3.2 Smart Fabric Belly Band
    • 8.3.3 Laborview Sensor System
    • 8.3.4 Bellabeat Interactive Monitoring Device
    • 8.3.5 Benchtop Semiconductor Sequencing Procedure
    • 8.3.6 Smart Sock Monitor

Chapter 9 Company Profiles

  • ABBOTT LABORATORIES
  • ABCAM PLC
  • AMBISEA TECHNOLOGY CORP., LTD.
  • ANSH LABS LLC
  • ATOM MEDICAL CORP.
  • AVIVA SYSTEMS BIOLOGY LLC
  • BECKMAN COULTER INC.
  • BERRY GENOMICS
  • BIONET AMERICA INC.
  • BISTOS Co., LTD.
  • CONTEC MEDICAL SYSTEMS CO. LTD.
  • COOPERSURGICAL INC.
  • CREATIVE DIAGNOSTICS
  • DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
  • DEMEDITEC DIAGNOSTICS GMBH
  • DRAGERWERK AG & CO.
  • DRE INC.
  • DRG INTERNATIONAL INC.
  • EAGLE BIOSCIENCES INC.
  • EDAN INSTRUMENTS INC.
  • ESAOTE SPA
  • FUKUDA DENSHI CO. LTD.
  • GE HEALTHCARE LTD.
  • GENERAL MEDITECH INC.
  • HITACHI MEDICAL SYSTEMS AMERICA INC.
  • HOLOGIC INC.
  • HUNTLEIGH HEALTHCARE LLC
  • ILLUMINA INC.
  • INFINIUM MEDICAL INC.
  • INSTITUTE OF ISOTOPES CO. LTD.
  • LEINCO TECHNOLOGIES INC.
  • LIFEWAVE BIOMEDICAL INC.
  • LUTECH INDUSTRIES INC.
  • M&B ELECTRONIC INSTRUMENTS CO. LTD.
  • MEDGYN PRODUCTS INC.
  • MEDIANA CO. LTD.
  • MEDICAL ECONET GMBH
  • MEDICHECKS LTD.
  • MINDCHILD MEDICAL INC.
  • MINDRAY MEDICAL INTERNATIONAL LTD.
  • MONOBIND INC.
  • MYRIAD GENETICS INC.
  • NATERA INC.
  • NATUS MEDICAL INC.
  • NEMO HEALTHCARE BV
  • NEOVENTA MEDICAL AB
  • NIHON KOHDEN CORP.
  • NONIN MEDICAL INC.
  • OB TOOLS LTD.
  • PENLON LTD.
  • PERKINELMER LIFE AND ANALYTICAL SCIENCES INC.
  • PHOENIX PHARMACEUTICALS INC.
  • PREMAITHA HEALTH LTD.
  • QUEST DIAGNOSTICS INC.
  • RAVGEN
  • RAYBIOTECH INC.
  • RESPIRONICS INC. (PHILIPS)
  • SEQUENOM INC.
  • SHENZHEN AEON TECHNOLOGY CO. LTD.
  • SHENZHEN COMEN MEDICAL INSTRUMENTS CO. LTD.
  • SHENZHEN JUMPER MEDICAL EQUIPMENT CO. LTD.
  • SIEMENS HEALTHCARE
  • SINOHERO BIOMEDICAL ELECTRONICS CO. LTD.
  • SMITHS MEDICAL INC.
  • SPACELABS HEALTHCARE INC.
  • TOSHIBA AMERICA MEDICAL SYSTEMS INC.
  • USCN LIFE SCIENCES INC.
  • ULTRASOUND TECHNOLOGIES LTD.
  • UNITED BIORESEARCH INC.
  • UTAH MEDICAL PRODUCTS INC.
  • VCOMIN TECHNOLOGY LTD.
  • WELCH ALLYN INC.

List of Tables

  • Summary Table A : Global Market for Fetal Monitoring, Diagnostics and Predictive Tests, by Application, Through 2027
  • Summary Table B : Global Market for Fetal Monitoring, Diagnostics and Predictive Tests, by End User, Through 2027
  • Table 1 : Maternal/Fetal Concerns Due to Certain Pre-Existing Maternal Conditions
  • Table 2 : Weight, Length, and Head Circumference, by Gestational Age
  • Table 3 : Weight, Length, and Head Circumference, by Gestational Age for Boys
  • Table 4 : Weight, Length, and Head Circumference, by Gestational Age for Girls
  • Table 5 : Classification of Preterm, Term and Post-Term Births
  • Table 6 : Survival Rates of Premature Babies
  • Table 7 : Long-Term Impact of Preterm Births on Survivors
  • Table 8 : Types of Preterm Births and Risk Factors
  • Table 9 : Top 20 Countries with Maximum Preterm Birth Rates
  • Table 10 : Gestational Age and Birthweight Characteristics, by Plurality: United States, 2020
  • Table 11 : Fetal Scalp Electrodes: Products and Vendors
  • Table 12 : Central Monitoring Stations: Products and Vendors
  • Table 13 : Products and Vendors of Gynecological and Obstetric Ultrasound Systems
  • Table 14 : Regulatory Approval: U.S. Versus Europe
  • Table 15 : Global Market for Fetal Monitoring, Prenatal Diagnostics and Neonatal Monitoring, by Region, Through 2027
  • Table 16 : Global Market for Electronic Fetal Monitors, by Region, Through 2027
  • Table 17 : Global Market for Fetal Monitoring by Fetal Dopplers, by Region, Through 2027
  • Table 18 : Global Market for Other Types of Fetal Monitoring, by Region, Through 2027
  • Table 19 : Global Market for Fetal Ultrasound, by Region, Through 2027
  • Table 20 : Global Market for Fetal MRI, by Region, Through 2027
  • Table 21 : Global Market for CVS, by Region, Through 2027
  • Table 22 : Global Market for Noninvasive cfDNA Tests, by Region, Through 2027
  • Table 23 : Global Market for PGD/PGS Tests, by Region, Through 2027
  • Table 24 : Global Market for Other Types of Prenatal Diagnostic Tests, by Region, Through 2027
  • Table 25 : Global Market for Neonatal Monitoring, by Region, Through 2027
  • Table 26 : Global Market for Predictive Genetic Tests, by Region, Through 2027
  • Table 27 : Prenatal Screening Tests, by Pregnancy Stage
  • Table 28 : Screening Test During Pregnancy
  • Table 29 : Selected Beta-HCG Kits and Vendors
  • Table 30 : Selected PAPP-A Test Kits and Vendors
  • Table 31 : Selected MSAFP Test Kits and Vendors
  • Table 32 : Selected uE3 Test Kits
  • Table 33 : Selected Inhibin-A Test Kits
  • Table 34 : Selected Maternal Hexosaminidase Test Kits
  • Table 35 : Second Trimester Maternal Serum Screening Analyte Patterns
  • Table 36 : Some Genetic Disorders That Can be Detected Before Birth
  • Table 37 : Prenatal Diagnostic Tests, by Pregnancy Stage
  • Table 38 : Five Biophysical Attributes Studied During BPP
  • Table 39 : Radiological Studies in Prenatal Diagnosis
  • Table 40 : Applications of Ultrasonography in Pregnancy
  • Table 41 : MRI Indications for Fetal Diagnosis When There are Ultrasound-Related Problems
  • Table 42 : Currently Available NGS Platform for NIPT
  • Table 43 : Commercially Available NGS Platform for CFDNA Tests
  • Table 44 : Genetic Disorders Detected, by Carrier Predictive Test
  • Table 45 : Leading Pharmaceuticals in Microbiome Therapeutics Partnerships
  • Table 46 : Chances of Being a Carrier of Genetic Disease
  • Table 47 : Commercially Available Genetic Tests for Carrier Screening
  • Table 48 : Comparison of Available PGD/PGS Technologies
  • Table 49 : Companies and Products for PGD Testing
  • Table 50 : Market Participants
  • Table 51 : Abbott Laboratories: Company Financials, 2021
  • Table 52 : Abbott Laboratories: Product Portfolio
  • Table 53 : Abcam plc: Company Financials, 2021
  • Table 54 : Abcam plc: Product Portfolio
  • Table 55 : Ambisea Technology Corp. Ltd.: Product Portfolio
  • Table 56 : Ansh Labs LLC: Product Portfolio
  • Table 57 : Ansh Labs LLC: Recent Developments, 2018
  • Table 58 : Atom Medical Corp.: Product Portfolio
  • Table 59 : Beckman Coulter Inc.: Product Portfolio
  • Table 60 : Berry Genomics: Product Portfolio
  • Table 61 : Bionet America Inc.: Product Portfolio
  • Table 62 : Bistos Co., Ltd.: Product Portfolio
  • Table 63 : Contect Medical Systems Co. Ltd.: Product Portfolio
  • Table 64 : CooperSurgical Inc.: Product Portfolio
  • Table 65 : Creative Diagnostics: Product Portfolio
  • Table 66 : Cortez Diagnostics Inc.: Product Portfolio
  • Table 67 : Demeditec Diagnostics: Product Portfolio
  • Table 68 : Dragerwerk AG & Co. KGaA: Product Portfolio
  • Table 69 : Clinical Data for Panorama Test

List of Figures

  • Summary Figure A : Global Market for Fetal Monitoring, Diagnostics and Predictive Tests, by Application, 2019-2027
  • Summary Figure B : Global Market for Fetal Monitoring, Diagnostics and Predictive Tests, by End User, 2019-2027
  • Figure 1 : Distribution of Small Fetuses Due to Fatal Growth Restrictions
  • Figure 2 : Risk Factors for Neonatal and Post Neonatal Deaths
  • Figure 3 : Global Market for Fetal Monitoring, Prenatal Diagnostics and Neonatal Monitoring, by Region, 2019-2027
  • Figure 4 : Global Market for Electronic Fetal Monitors, by Region, 2019-2027
  • Figure 5 : Global Market for Fetal Monitoring by Fetal Dopplers, by Region, 2019-2027
  • Figure 6 : Global Market for Other Types of Fetal Monitoring, by Region, 2019-2027
  • Figure 7 : Global Market for Fetal Ultrasound, by Region, 2019-2027
  • Figure 8 : Global Market for Fetal MRI, by Region, 2019-2027
  • Figure 9 : Global Market for CVS, by Region, 2019-2027
  • Figure 10 : Global Market for Noninvasive cfDNA Tests, by Region, 2019-2027
  • Figure 11 : Global Market for PGD/PGS Tests, by Region, 2019-2027
  • Figure 12 : Global Market for Other Types of Prenatal Diagnostic Tests, by Region, 2019-2027
  • Figure 13 : Global Market for Neonatal Monitoring, by Region, 2019-2027
  • Figure 14 : Causes of Fetal Abnormalities
  • Figure 15 : Abbott Laboratories: Revenue Share, by Business Segment, 2021
  • Figure 16 : Abbott Laboratories: Revenue Share, by Region, 2021